Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest: A Phase III Multi-Centre Randomised Controlled Trial (The TAME Cardiac Arrest Trial)

Bernard, Stephen (Primary Chief Investigator (PCI))
Eastwood, Glenn (Chief Investigator (CI))
Bellomo, Rinaldo (Chief Investigator (CI))
Stub, Dion (Chief Investigator (CI))
Archer, John A.C. (Chief Investigator (CI))
Hodgson, Carol (Chief Investigator (CI))

Epidemiology and Preventive Medicine Alfred Hospital

Project: Research

Status	Finished
Effective start/end date	1/01/17 → 31/12/22

Funding

National Health and Medical Research Council (NHMRC) (Australia): A$2,069,878.00

1 Article

Protocol summary and statistical analysis plan for the Targeted Therapeutic Mild Hypercapnia after Resuscitated Cardiac Arrest (TAME) trial
Nichol, A., Bellomo, R., Ady, B., Nielsen, N., Hodgson, C., Parke, R., McGuinness, S., Skrifvars, M., Stub, D., Bernard, S., Taccone, F., Archer, J., Neto, A. S., Trapani, T., Ainscough, K., Hunt, A., Kutsogiannis, J., Eastwood, G. M. & for the TAME study and the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG), the Irish Critical Care Clinical Trials Network (ICC-CTN), and the Australian Resuscitation Outcomes Consortium (Aus-ROC), Dec 2021, In: Critical Care and Resuscitation. 23, 4, p. 374-385 12 p.
Research output: Contribution to journal › Article › Other › peer-review

5 Citations (Scopus)